- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
PMCPA case AUTH/3119/11/18 (Director v Pfizer) about clinical trial disclosure. The matter was ruled outwith the scope of the ABPI Code (2016).…
PMCPA took up a BMJ analysis of EUCTR reporting. Allergan was found in breach of Clause 9.1 for late EUCTR results posting…
Anonymous complaint alleged misleading trial claims and a “switch programme” for Adcal-D3 Caplet. Panel found no breach for promo materials or therapy…
Pharmacosmos alleged Vifor reps misled HCPs that Monofer total dose infusion had a 1,000mg max. Panel found evidence insufficient on balance of…
Anonymous complaint alleged two Allergan employees were removed from a Merz symposium for photographing/recording despite warnings. Panel found insufficient evidence of poor…
A GP alleged Trajenta “with a difference” claims were misleading vs other DPP-4 inhibitors (dose adjustment, renal monitoring, food). Panel and Appeal…
A GP said he was misled into attending what he thought was EvoInserter training for Mirena. PMCPA found the ‘Mirena training workshop’…
Anonymous NHS HCPs complained about excessive hospitality at a 5-star Belfast urology meeting with golf and a gala dinner. Janssen was found…
Anonymous complaint alleged Chugai staff bought rounds of drinks for health professionals in a hotel bar after a conference dinner. Chugai denied…
A GP complained that Hidrasec ads were visible on Facebook. The Panel ruled this effectively promoted a prescription-only medicine to the public…
A pharmacist alleged Leo’s pre-printed ‘Dear Dr’ forms for Picato were used to bypass local formulary status. PMCPA found the material didn’t…
Shire self-referred use of a Lancet reprint containing an incorrect bar chart about competitor Fabrazyme. Although the correction was included at the…
Astellas admitted an error in a BMJ-distributed “consensus statement” where the sponsorship declaration understated its role. The Panel found disguised promotion, misleading…
Bausch & Lomb was ruled in breach after “new” claims for Emerade remained on an HCP website page despite an undertaking in…
Complaint alleged off-label discussion and research grant promotion at a Boehringer Ingelheim ESC 2015 symposium. Panel found no evidence of off-label promotion…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.